Monoclonal Antibodies at the Heart of Biopharmaceutical Innovation
The field of biopharmaceuticals is experiencing a profound transformation, with monoclonal antibodies (mAbs) leading the charge in therapeutic innovation. As the demand for these life-changing therapies surges, a specialized sector of solution providers …